Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global Phage Therapy market size is projected to reach US$ 100.8 million by 2028, from US$ 32 million in 2021, at a CAGR of 17.6% during 2022-2028.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Phage Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Phage Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Phage Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Phage Therapy market.
Request for a free sample or purchase this report at: https://www.themarketreports.com/report/global-phage-therapy-market-research-report
Phage Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Phage Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
Segment by Application
- Animal Health
- Food Industry
- Human Health
- Npo Microgen
- Proteon Pharmaceuticals
- Eliava Biopreparations
- Locus Biosciences,Inc
- Pharmex Group,Llc
- Pherecydes Pharma
- Aps Biocontrol Ltd. (Aps)
- Qingdao Phagepharm Bio-Tech
- Fixed-Phage Limited
- Phage International, Inc.
- Intodeworld, Inc.
- Armata Pharmaceuticals, Inc.
- Adaptive Phage Therapeutics
Production by Region
- North America
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Mr. Shirish Gupta
The Market Reports | Industry and Market Reports at its Best
Call: +1-631-407-1315 / +91-750-729-1479